Safety and efficacy of a modular digital psychotherapy for social anxiety: A randomized controlled trial
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Social anxiety disorder is a common mental health condition characterized by an intense fear of social situations which can lead to significant impairment in daily life. Cognitive behavioral therapy (CBT) has been recognized as an effective treatment; however, access to therapists is limited and the fear of interacting with therapists can delay treatment seeking. Furthermore, not all individuals respond. Tailoring modular treatments to individual cognitive profiles may improve efficacy. We developed a novel digital adaptation of CBT for social anxiety that is both modular and fully digital without therapist in the loop and implemented it in a smartphone app.
Objective
To evaluate the safety, acceptability and efficacy of the new treatment in online participants with symptoms of social anxiety
Methods
Two online randomized controlled trials comparing individuals with access to the treatment through the app to waitlist. Participants were recruited online and reported Social Phobia Inventory (SPIN) total scores >= 30. Primary outcomes were safety and efficacy over 6 weeks in 102 women aged 18-35 (RCT #1) and symptom reduction (Social Phobia Inventory total scores) after 8 weeks in 267 men and women aged 18-75 (RCT #2).
Results
In RCT #1, active and control arm adverse event frequency and severity was not distinguishable. App acceptability was high. Secondary outcomes suggested greater symptom reduction in the active (-9.83 ± 12.80) than the control arm (-4.13 ± 11.59, t 90 = -2.23, p FDR = .037, Cohen’s d = 0.47). In RCT #2, there was a higher symptom reduction in the active arm (-12.89 ± 13.87) than the control arm (-7.48 ± 12.24, t 227 = - 3.13, p FDR = .008, Cohen’s d = 0.42).
Conclusions
The online-only, modular social anxiety CBT program appears safe, acceptable and efficacious in an online patient group with self-reported symptoms of social anxiety.
Trial Registration
RCT #1: ClinicalTrials.gov NCT05858294 , RCT #2: ClinicalTrials.gov NCT05987969
